| Literature DB >> 10817751 |
X X Bin1, K Wolf, T Schaffner, R Malinverni.
Abstract
The effects of treatment with azithromycin plus rifampin (A+R), amoxicillin (A), or placebo (P) on the chronic course of experimental Chlamydia pneumoniae pneumonitis in mice were assessed by culture, PCR, and immunocytochemistry as well as by degree of inflammation in lung tissue. Eradication of the pathogen was significantly more frequent and inflammation in tissue was significantly reduced after treatment with A+R compared to after treatment with A or P. Combination therapy with azithromycin plus rifampin showed favorable effects in the chronic course of C. pneumoniae pneumonitis.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10817751 PMCID: PMC89955 DOI: 10.1128/AAC.44.6.1761-1764.2000
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191